UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_29243/2025

REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

Procedural & sub-applicationsDocument Access (RoP262)Munich LDApplication RoP262A—
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Promosome LLC
Reps: Georg A. Rauh (Vossius & Partner)

Respondents

  • BioNTech SE
  • BioNTech Manufacturing GmbH
  • BioNTech Manufacturing Marburg GmbH
  • BioNTech Innovative Manufacturing Services GmbH
  • BioNTech Europe GmbH
  • Pfizer Manufacturing Belgium NV
  • Pfizer SAS
  • Pfizer AB
  • Pfizer, Inc.
Reps: Christine Kanz (HOYNG ROKH MONEGIER)
Judges
  • András KupeczJudge-Rapporteur (Munich Local Division, Panel 2)
Patents
  • EP 2 401 365
CPC codes: C12P21/00, C12N15/111, C12P21/02, C12N15/63, C12N15/67, C12N2310/141, C12N2320/53, C12N2320/50

Sector: Biotechnology

Outcome
Procedural only
Filed: —
First decided: Jul 15, 2025
Language: —